“Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s480. https://doi.org/10.25251/skin.8.supp.480.